CLINICAL_TRIALS
research
· 2026-04-08
Clinical Trial Update: A Study of Ivonescimab in People With Leiomyosarcoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating Ivonescimab for leiomyosarcoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leiomyosarcoma | Phase 2 | Status: RECRUITING